Advanced technologies and tools are central to the ongoing search for effective treatments for depression. Ace Therapeutics, a leading neuroscience and psychiatric research company, has expanded its well-accepted depression-related behavior testing services with its full range of depression animal models. This growth reinforces Ace Therapeutics’ dedication to advancing drug...
Ace Therapeutics, a pioneering pre-clinical CROs for stroke, is pleased to announce its rodent stroke behavior testing services. These tests offer scientists valuable measurement methods for evaluating functional recovery and therapeutic efficacy in stroke studies and accelerating the development of novel therapies.
“Our behavioral testing system allows researchers to precisely...
Ace Therapeutics, a contract research organization (CRO) based in the United States, is excited to announce the launch of its groundbreaking glaucoma gene therapy development services. This new initiative is set to advance research in glaucoma treatments, offering comprehensive support and innovation for researchers and pharmaceutical companies aiming to cure this pervasive eye disease.
...
Ace Therapeutics, a contract research organization engaged in cardiovascular disease research, is proud to announce the launch of its cardiovascular disease model development services, aiming to empower researchers and pharmaceutical companies with advanced tools and models to accelerate the study of cardiovascular diseases and drug discovery.
Cardiovascular disease (CVD) remains a...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek